Under the agreement, MMA.INC will market Precision's products across its global combat sports ecosystem and will receive 50% of net revenue derived from MMA-Sourced Sales during the first twelve months of the partnership, followed by an ongoing 25% share of net revenue from MMA-Sourced Sales for the remainder of the Term.

Commercial Overview

We believe the agreement establishes a new high margin, revenue-generating vertical for MMA.INC with no capital investment requirements, while granting the Company exclusive rights to market Precision's peptide products across its global combat sports ecosystem, including TrainAlta, BJJLink, MixedMartialArts.com and its broader network of academies, athletes, coaches and combat sports participants.

Under the commercial terms of the agreement, net revenue derived from MMA-sourced customer sales will initially be shared equally between MMA.INC and Precision on a 50/50 basis during the first twelve months of the partnership before transitioning to a 25/75 split thereafter. The structure directly aligns both companies around customer acquisition, conversion, repeat purchasing and long-term commercialization growth.

The partnership may be terminated by either party upon no less than thirty (30) days' prior written notice. Following termination or expiration, MMA.INC will continue receiving its applicable revenue share on sales to MMA-referred customers for a twelve (12) month tail period.

All peptide products sold under the partnership will be manufactured in the United States of America and comply with all applicable U.S. regulatory requirements and standards, including those of the U.S. Food and Drug Administration and other applicable regulatory authorities.

Why MMA.INC is Expanding Into the High-Growth Recovery and Longevity Market

MMA.INC believes the partnership provides direct exposure to one of the fastest-growing categories across recovery optimization, regenerative medicine, preventative health, metabolic wellness, longevity and human performance.

The peptide sector has rapidly expanded in recent years as consumer demand for advanced recovery, performance optimization and wellness solutions has accelerated. At the same time, increasing regulatory scrutiny around manufacturing standards, product quality, labeling and commercialization practices is expected to accelerate a broader industry shift toward compliant, domestically manufactured and quality-controlled providers.

Historically, large portions of the peptide market have operated through fragmented offshore manufacturing and grey-market distribution channels with inconsistent quality standards. MMA.INC believes this industry transition creates a significant opportunity for premium operators capable of meeting higher compliance and manufacturing standards.

Precision's products are manufactured in the United States and undergo third-party testing protocols designed to emphasize purity, consistency and quality assurance standards.

The partnership is strategically aligned with MMA.INC's rapidly expanding combat sports participation ecosystem. Brazilian Jiu-Jitsu, mixed martial arts, wrestling, boxing and related disciplines place significant physical demands on participants, creating natural demand for advanced recovery, resilience and performance optimization solutions.

MMA.INC currently operates one of the world's largest digitally connected combat sports ecosystems, with approximately 530,000 user profiles, more than 75,000 active students and over 800 verified gyms globally.

The Company believes this ecosystem creates a differentiated direct-to-consumer commercialization channel into one of the world's most engaged athletic demographics, while further expanding MMA.INC's broader strategy to build a vertically integrated participation platform spanning training, technology, recovery, wellness and performance optimization.